Cold chain packaging was built for a stable world. As disruption becomes the norm, pharma logistics teams are rethinking what control actually means and when it has to happen.

in the post-acute care industry. However, a niche role that often goes unnoticed is that of a consultant pharmacist, who contracts with post-acute care providers to deliver expert guidance on the safe ...

Erez Israeli explains how Dr. Reddy's approached commercial readiness for its generic semaglutide launch in Canada and what vertical integration in peptide manufacturing means for the GLP-1 market.

Learn how early regulatory, evidence, manufacturing, and EU access planning keeps CGT launches on track, from CoI logistics to payer coverage.

As patient expectations continue to evolve, brick-and-mortar pharmacy’s path forward lies in combining trusted, face-to-face ...

Explain why commercialization readiness begins much sooner than executives think. Identify early operational ...

Identify early operational decisions—product handling requirements, product configuration, transportation strategies, temperature management requirements, and supply chain design—that affect ...

Cell and gene therapies (CGTs) hold tremendous promise for patients. But bringing them to market requires manufacturers to navigate regulatory, operational, and market access challenges that begin ...